Dormant
ZENA · ZenaTech, Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on the last session; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Current thesis
ZenaTech's recovery case requires a priced commercial drone-service contract and a weekly close above the market's August 28 close of $1.71. A weekly close below $1.52 invalidates that case; September's development announcements have not established their revenue contribution.
Kill line
A weekly close below $1.52 invalidates the commercial recovery case by losing the 2026-09-11 reference close. The earlier tariff thesis already breached its published $1.70 threshold.
Pick status
Open commitment catalyst 6d agoscored if the kill line above fires How this is scored →Latest analysis and events for ZENA —
As of 13 September 2026, the latest FrontierPicks analysis for ZenaTech, Inc. (ZENA): ZenaTech's recovery case requires a priced commercial drone-service contract and a weekly close above the market's August 28 close of $1.71. A weekly close below $1.52 invalidates that case; September's development announcements have not established their revenue contribution.
Kill line: A weekly close below $1.52 invalidates the commercial recovery case by losing the 2026-09-11 reference close. The earlier tariff thesis already breached its published $1.70 threshold.
Most recent dated event on file: — catalyst 6d ago.
Current Thesis
ZenaTech's recovery case requires a priced commercial drone-service contract and a weekly close above the market's 2026-08-28 close of $1.71; a weekly close below $1.52 ends that case. September's prototype, franchise and operating-authorization announcements provide developments to assess, but the supplied evidence does not quantify their revenue contribution.
The earlier tariff thesis has already failed its published price condition: the 2026-09-11 adjusted close of $1.52 is below the prior $1.70 weekly threshold. For that tariff-driven advance, the narrative is dead — the September 11 close remains below the August 28 close even after the previously scheduled September 3 policy milestone. The commercial recovery case is a separate, low-confidence possibility, rather than an extension of the invalidated price thesis.
The substantive development since the August 29 note is ZenaTech's September 10 announcement of Irish Aviation Authority operational authorization for drone-based crop and soil nutrient application services. That is company-reported regulatory progress; it does not establish the value of customer demand. ZenaTech announcement, 2026-09-10
Bullish and bearish views on ZenaTech, Inc.
The model's bull view on ZenaTech, Inc. (ZENA), in brief: Agricultural prototype reaches testing stage. The bear view: Price has breached prior conditions. The supplied 2026-09-11 adjusted close of $1.52 is below both the previously published $1.70 invalidation threshold and the market's 2026-08-28 close of $1.71. September's announcements have therefore not restored the earlier price structure.… Both cases follow in full.
Bull Case
- Agricultural prototype reaches testing stage. On 2026-09-03, ZenaTech announced completion of the initial IQ Octo prototype and expected Arizona field testing in the coming weeks. This establishes a development milestone; successful field operation remains unverified. Company release
- Franchise infrastructure already exists. The 2026-09-08 power-washing announcement ties the proposed drone franchise strategy to Green Earth Powerwashing, acquired on 2026-06-23 with an existing registered franchise system and franchisees. The infrastructure is identified, while the drone-based franchise business remains a plan. Company release
- Irish authorization advances service readiness. ZenaTech's 2026-09-10 announcement identifies an operational authorization for crop and soil nutrient applications. This supports the commercialization case at the authorization stage; the evidence reviewed supplies no associated contract value. Company announcement
Bear Case
- Price has breached prior conditions. The supplied 2026-09-11 adjusted close of $1.52 is below both the previously published $1.70 invalidation threshold and the market's 2026-08-28 close of $1.71. September's announcements have therefore not restored the earlier price structure.
- Product timing remains imprecise. The 2026-09-03 IQ Octo release schedules field testing only for the coming weeks. It supplies no calendar date for completed testing, making a dated commercial-readiness forecast unsupported. Company release
- Earnings calendars do not establish results. MarketBeat's page dated 2026-09-08 lists actual quarterly revenue and earnings per share as unavailable. That page cannot establish that results were released, and the evidence reviewed does not establish a company-confirmed next reporting date. MarketBeat earnings page
Setup & Price Structure
Measured on 2026-09-11, the supplied adjusted series shows a $1.52 daily close, a 14-period relative strength index of 25.2 and a three-month price increase of 8.6%. The shares are 77.3% below the supplied 52-week high of $6.69. Those observations establish weak recent momentum; they do not establish a reversal.
The $1.52 reference close is the prospective recovery case's observable boundary, not a demonstrated support shelf. A weekly close above $1.71 would satisfy its price-repair requirement because $1.71 was the market's August 28 close. The fundamental requirement remains a disclosed commercial drone-service contract with a stated value.
Retail discussion clustered around the September 8 franchise announcement and September 10 Irish authorization, with posts dated September 10 and September 11 respectively. These observations establish discussion of recent releases; the sample is too small to support a crowding claim. Short interest, borrow costs, trading-volume participation and moving-average distance are missing from the supplied evidence. September 10 discussion, September 11 discussion
Catalyst Calendar (next 30 days)
- 2026-09-28 through 2026-10-02: The same September 1 release schedules investor meetings in Berlin, Munich, Frankfurt and London. These are opportunities for disclosed commercial detail; attendance alone does not satisfy the recovery thesis. Company event schedule
The previously listed 2026-09-03 catalyst has elapsed. Neither an exact IQ Octo testing-completion date nor a company-confirmed earnings date is established by the reviewed evidence, so neither is assigned an upcoming date here.
Elapsed catalysts
- 2026-09-14 through 2026-09-16: ZenaTech scheduled participation in the H.C. Wainwright Global Investment Conference in New York. The September 1 announcement establishes an investor-presentation window, without promising financial results or contracts. Company event schedule (passed 4d ago)
What Would Change Our Mind
Failure to retain the September 11 reference close would break the prospective recovery structure: a weekly close below $1.52 invalidates this case. This condition does not revise the earlier thesis's outcome; its $1.70 threshold has already been breached.
Evidence for rehabilitation requires both a weekly close above the August 28 reference close of $1.71 and a disclosed, priced commercial drone-service contract. The September 3 prototype announcement, September 8 franchise plan and September 10 authorization establish development activity, but do not themselves satisfy that commercial test.
Correlation Notes
The supplied August 14 Benzinga coverage grouped ZenaTech's policy context with Ondas, Draganfly and Red Cat. That historical coverage establishes a shared headline, not a measured return correlation. No comparable September peer-price series is supplied, so the September 11 ZENA close cannot establish whether the weakness is company-specific or sector-wide.
The present recovery case is a single-name assessment of ZenaTech's September commercial announcements. No group-move forecast is supported by the available comparison data.
Notes
- Foreign private issuer: reports on Forms 6-K and 20-F and is exempt from Section 16, so no Form 4 record of insider buying or selling exists for US readers.
- Press coverage has quoted Q1 2026 revenue as both $8.40M and C$8.3M. Confirm the reporting currency in the filed statements before modelling.
- May 2026 capital structure includes 11,792,455 warrants at a $2.50 strike, 1,605,551 other warrants, and preferred convertible on a 3-for-1 ratio.
- Growth is acquisition-led: 28 Drone-as-a-Service deals closed as of 2026-08-20, plus the ESM Software deal on 2026-08-25. No organic-versus-acquired revenue split has been published.
- Recent acquisitions (2026-08-20, 2026-08-25) were announced with financial terms undisclosed, so consideration and settlement currency are not public.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
ARCB
ArcBest Corporation
ArcBest’s cost-reduction rebound failed its published price condition at the 2026-09-18 weekly close of $128.73. Third-quarter results still test recurring savings and preservation of the second-quarter 90.8% adjusted Asset-Based operating ratio, but cannot undo that invalidation.
JBHT
J.B. Hunt Transport Services, Inc.
J.B. Hunt’s freight-recovery thesis was invalidated by the 2026-09-18 weekly close below $265. The estimated 2026-10-15 report tests whether intermodal pricing and profit growth can support a separate recovery case after September’s cost warning.